Isolation of Aspergillus lentulus in Spain from a critically ill patient with chronic obstructive pulmonary disease

Revista Iberoamericana de Micologia

Volumn 25, Issue 4, 2008, Pages 246-249

  Alhambra, Almudena ^a   Catalán, Mercedes ^a   Moragues, María Dolores ^b   Brena, Sonia ^b   Pontón, José ^b   Montejo, Juan Carlos ^a   Del Palacio, Amalia ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

(1 3) beta D glucan; Antifungals; Aspergillus fumigatus; Aspergillus lentulus; Chronic obstructive pulmonary disease; Corticosteroids; GOPD; Spain

Indexed keywords

AMPHOTERICIN B; BETA 1,3 GLUCAN; CASPOFUNGIN; CORTICOSTEROID; ITRACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT;

ACUTE RESPIRATORY FAILURE; AGED; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS LENTULUS; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CRITICALLY ILL PATIENT; DISEASE EXACERBATION; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS ISOLATION; HUMAN; INTENSIVE CARE; LUNG ASPERGILLOSIS; MALE; MINIMUM INHIBITORY CONCENTRATION; MIXED INFECTION; MULTIPLE ORGAN FAILURE; NONHUMAN; SPAIN; TRANSBRONCHIAL ASPIRATION; ASPERGILLOSIS; CRITICAL ILLNESS; FATALITY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG LAVAGE; LUNG MYCOSIS; MICROBIOLOGY; MULTIDRUG RESISTANCE; OPPORTUNISTIC INFECTION; PATHOGENICITY; RESPIRATORY FAILURE; SMOKING; SPECIES DIFFERENCE;

ASPERGILLUS FUMIGATUS; ASPERGILLUS LENTULUS;

ADRENAL CORTEX HORMONES; AGED; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FUMIGATUS; BRONCHOALVEOLAR LAVAGE FLUID; CRITICAL ILLNESS; DRUG RESISTANCE, MULTIPLE, FUNGAL; FATAL OUTCOME; HUMANS; LUNG DISEASES, FUNGAL; MALE; OPPORTUNISTIC INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; SMOKING; SPECIES SPECIFICITY;

EID: 61449285724     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-1406(08)70058-5     Document Type: Article

References (18)

1. Ascioglu S, Rex JH, de PB, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ; Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
2. Balajee SA, Gribskov JL, Hanley E, Nickle D, Marr KA. Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot Cell 2005; 4: 625-632.
3. Balajee SA, Nickle D, Varga J, Marr KA. Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping. Eukaryot Cell 2006; 5: 1705-1712.
4. Balloy V, Huerre M, Latge JP, Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005; 73: 494-503.
5. Cordonnier C, Botterel F, Pautas C, Maury S, Kuentz M, Bretagne S. Galactomannan antigenaemia has a higher diagnostic yield in invasive aspergillosis in deeply neutropenic patients than in others. Bone Marrow Transplant 2007; 37: P674.
6. Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, Chevrier S, Meunier C, Lebert C, Aupée M, Caulet-Maugendre S, Faucheux M, Lelong B, Leray E, Guiguen C, Gangneux JP. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 2006; 43: 577-584.
7. Denning DW. Aspergillosis in "nonimmunocompromised" critically ill patients. Am J Respir Crit Care Med 2004; 170: 580-581.
8. Guarro J, GeneJ, Stchigel AM. Developments in fungal taxonomy. Clin Microbiol Rev 1999; 12: 454-500.
9. Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet 2003; 362: 1828-1838.
10. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van WE. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170: 621-625.
11. Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007; 45:205-216.
12. Montejo JC, del Palacio A. Importancia de la candididasis invasora en el enfermo crítico no neutropénico. Rev Iberoam Micol 2006; 23: 2-3.
13. Muquim A, Dial S, Menzies D. Invasive aspergillosis in patients with chronic obstructive pulmonary diseases. Can Respir J 2005; 12: 199-204.
14. Ng TT, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology 1994; 140: 2475-2479.
15. Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998; 26: 1473-1475.
16. Samson RA, Hong SB, Frisvad JC. Old and new concepts of species differentiation in Aspergillus. Med Mycol 2006; 44: 133-148.
17. Vandewoude KH, Vogelaers D. Medical imaging and timely diagnosis of invasive pulmonary aspergillosis. Clin Infect Dis 2007; 44: 380-381.
18. Yaguchi T, Horie Y, Tanaka R, Matsuzawa T, Ito J, Nishimura K. Molecular phylogenetics of múltiple genes on Aspergillus section Fumigati isolated from clinical specimens in Japan. Jpn J Med Mycol 2007; 48: 37-46.